[March 13, 2013]

Research and Markets: Lupus Nephritis Global Clinical Trials Review, H1, 2013 Includes an Overview of the Trial Numbers and Their Recruitment Status

Research and Markets (http://www.researchandmarkets.com/research/6vbp7c/lupus_nephritis) has announced the addition of GlobalData's new report "Lupus Nephritis Global Clinical Trials Review, H1, 2013" to their offering.

The clinical trial report, Lupus Nephritis Global Clinical Trials Review, H1, 2013" provides data on the Lupus Nephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lupus Nephritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lupus Nephritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and rlevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-Pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

Companies Mentioned:

Astellas Pharma Inc.

Novartis AG

Clinical Trial Overview of Novartis AG

Genentech, Inc.

Clinical Trial Overview of Genentech, Inc.

Merck KGaA

Clinical Trial Overview of Merck KGaA

Anthera Pharmaceuticals Inc.

La Jolla Pharmaceutical Company

F. Hoffmann-La Roche Ltd.

Janssen Research & Development, LLC

Bristol-Myers Squibb Company

Cytomed

Clinical Trial Overview of Cytomed

SuppreMol GmbH

Clinical Trial Overview of SuppreMol GmbH

Baxter International Inc.

Teva Pharmaceutical Industries Limited

Nippon Kayaku Co., Ltd.

Human Genome Sciences, Inc.

Biogen Idec Inc.

Nanjing University

Chinese University of Hong Kong

Sun Yat-sen University

Faculty of Pharmaceutical Sciences, Chulalongkorn University

Zhejiang University

Tuen Mun Hospital

University Medical Center Groningen

Saitama Medical University

Ramathibodi Hospital

Universite Catholique de Louvain

Peking University

The Rogosin Institute

Katholieke Universiteit Leuven

The University of Hong Kong

Shanghai Jiao Tong University

Hospital Authority

Assistance Publique Hopitaux De Marseille

Seoul National University Hospital

For more information visit http://www.researchandmarkets.com/research/6vbp7c/lupus_nephritis

Source (News - Alert): GlobalData

[ Back To Technology News's Homepage ]